TrialCPT: pharmacometrics & systems pharmacology2025

Population Pharmacokinetics and Exposure-Response of Subcutaneous Atezolizumab in Patients With Non-Small Cell Lung Cancer.

Phyllis Chan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.